Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
142.74
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
53
54
Next >
The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months
March 27, 2024
Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months.
Via
InvestorPlace
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
March 26, 2024
Krispy Kreme's partnership with McDonald's has led to a surge in stock prices. Investors are turning to insulin stocks to capitalize on the growing demand.
Via
Benzinga
Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
March 26, 2024
Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its...
Via
Benzinga
3 Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
Look for these stocks to buy to continue moving higher in coming quarters propelled by multiple catalysts and strong earnings.
Via
InvestorPlace
Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today
March 26, 2024
Via
Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
March 25, 2024
Via
Benzinga
Decoding 7 Analyst Evaluations For Novo Nordisk
March 20, 2024
Via
Benzinga
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
March 26, 2024
Their joint project is cutting-edge, but it won't pay off immediately.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days
March 26, 2024
People lost more weight than the company expected over a 28-day study.
Via
Investor's Business Daily
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
March 26, 2024
All three of these high-flying stocks could have more room to run.
Via
The Motley Fool
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
March 26, 2024
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via
Investor's Business Daily
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
March 25, 2024
Artificial intelligence (AI) could play a big role in medical breakthroughs.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
March 25, 2024
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.
Via
Benzinga
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
March 25, 2024
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
Via
The Motley Fool
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Viking Therapeutics Stock a Millionaire Maker?
March 24, 2024
Viking Therapeutics has become one of the hottest healthcare stocks of 2024.
Via
The Motley Fool
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
March 23, 2024
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
Via
Talk Markets
How Are Obesity Drugs And Nvidia Related? Success Of Ozempic, Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development
March 22, 2024
Novo Nordisk Foundation partners with Eviden and Nvidia to pioneer AI-driven healthcare solutions. Expect the Gefion supercomputer to revolutionize drug discovery, supported by tech giants and the Novo...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
March 22, 2024
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Via
The Motley Fool
Did Eli Lilly Just One-Up Novo Nordisk?
March 22, 2024
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments.
Via
The Motley Fool
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
March 21, 2024
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.
Via
InvestorPlace
Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.
March 21, 2024
Novo Nordisk's Wegovy recently gained Food and Drug Administration approval to reduce the risk of cardiovascular problems.
Via
Investor's Business Daily
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health
March 21, 2024
Medicare considers extending coverage for Novo Nordisk's Wegovy to eligible members with heart disease history. CMS may include anti-obesity drugs under certain Medicare Part D plans. Germany's health...
Via
Benzinga
7 Stocks That Are Creating a Buzz on Wall Street
March 21, 2024
Buy these stocks creating buzz in order to inject some green into your portfolio and give your investment returns a boost.
Via
InvestorPlace
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
March 21, 2024
Has Novo Nordisk's already red-hot stock become an even better buy?
Via
The Motley Fool
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions
March 20, 2024
Eli Lilly stock is up 32% so far in 2024 and has risen 318% over three years.
Via
Benzinga
3 Biopharma Stocks Predicted to Soar in Q2 2024
March 20, 2024
These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
Via
Benzinga
Novo Nordisk Stock Stalls On Oprah TV Special, But Reddit Traders Believe It's 'Not Done Yet'
March 20, 2024
Retail investors are talking about a slim group of topics on Reddit this week including Novo Nordisk, weight-loss drug Ozempic and talk show host Oprah Winfrey.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.